naringenin has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, XF; Jiao, X; Song, WX; Wang, K; Wu, P; Wu, WY; Xiao, PQ; Zhan, SF | 1 |
Hu, C; Li, Q; Liu, X; Shi, Z; Sun, C; Zhao, T | 1 |
Choi, BT; Choi, YH; Hwang, HJ; Jin, CY; Kim, GY; Kim, WJ; Park, C | 1 |
Bak, Y; Hong, J; Jung, KY; Kang, JW; Kim, H; Kim, JH; Kim, MS; Lee, DH; Lim, Y; Park, YS; Yoon, DY | 1 |
4 other study(ies) available for naringenin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Topics: Antiviral Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; COVID-19; Humans; Lung Neoplasms; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases | 2023 |
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells.
Topics: Antineoplastic Agents; Apigenin; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Lung Neoplasms | 2023 |
Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Resistance, Neoplasm; Drug Synergism; Estrogen Antagonists; Flavanones; Gene Silencing; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2011 |
A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Fas Ligand Protein; fas Receptor; Flavanones; Humans; Hydrazones; Lung Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Up-Regulation | 2011 |